Académique Documents
Professionnel Documents
Culture Documents
Aneurysm (GSE36791)
1
Department of Physical Sciences, College of Science, Polytechnic University of the
*
corresponding author: leanaherrera@yahoo.com
2
Abstract
that may result to death or serious disability of some survivors. Knowledge of the
therapeutic remedies for the SAH patients or prevention of this disease. Such
expression of 43 RIA samples and 18 control samples was executed using XLStat 2016
with its feature Differential Expression. Gene ontology terms found upon entering the
probe ID of each differentially expressed genes to DAVID were used for functional
analysis of the said genes. In determining which pathways the differentially expressed
genes were associated to RIA, KEGG pathway was employed while STRING was for
cell differentiation, T cell receptor signalling pathway and hematopoietic cell lineage.
This explains why immune system process is the most significantly enriched biological
process. On the other hand, some upregulated genes were involved in inflammatory
Key words: intracranial aneurysm, subarachnoid hemorrhage, microarray, Gene Ontology, T cell
3
Introduction
Intracranial aneurysm (IA) is a dilating part of an artery that carries blood to the
hemorrhage (SAH) wherein 50% of the cases are fatal and some survivors suffer from
serious disability (Tromp et al., 2014). Risk factors include polycystic kidney disease,
smoking, increasing age, female gender, hypertension, and family history. Both ruptured
endovascular coiling (Chalouhi et al., 2013). These two treatments, however, are
invasive processes that may hasten the condition of a patient. Moreover, majority of the
Filipino patients could not afford the cost of these surgical operations.
Microarray technique has been used in the field of medicine to determine gene
variants of a gene in a given human population could give insights on the susceptibility
Microarray data for this study were gathered from GEO DataSets with accession
number GSE36791, wherein samples were collected from peripheral blood of SAH
4
patients and control group. Tools available online were used in performing analyses of
the data.
aneurysm (IA) and its causation could provide a system for administering SAH patients
BeadChip with more than 47000 probes, each representing oligonucleotide chain of 50
bases. The aneurysm group was composed of 43 samples and the control group had 18
samples.
Comparison of the two groups was performed using an add-in tool for MS Excel,
XLStat 2016, with its feature Differential Expression. Benjamini-Hochberg method under
nonparametric test was chosen and the genes with p-value less than 0.05 were
generated. The fold change of each gene was calculated by log 2(RIA/control). Genes
with p-value < 0.05 and absolute log2FC 0.585 were considered as differentially
expressed. A positive log2(FC) value means a gene from RIA sample is upregulated
helps researchers to comprehend biological terms from a vast list of genes and
identifying these probes, ILLUMINA_ID was selected before submitting the gene list to
in each term were included in the functional annotation chart. GO terms with Benjamini
p-value < 0.05 and Fold change > 2 were denoted as significantly enriched or
overrepresented.
maps characterizing information on various cell functions. KEGG pathway mapping has
The pathway map may explain further the biological processes related to
ruptured intracranial aneurysm and its complications. Same threshold values for the
Gene Ontology terms were used for the pathways to be considered as significantly
enriched or overrepresented.
Network Analysis
(STRING) was used in this analysis. Gene symbol of each differentially expressed gene
produced by protein-coding genes. Colored nodes denote proteins that are included in
first shell of interactors, and white nodes are for second shell of interactors. Edges
cooperatively contribute to a shared function. This however, does not necessarily mean
This more astringent fold change value was used to make the analysis easier.
Genetic variants and the differentially expressed genes with more astringent
aneurysm patients. From 47234 genes, 259 of which have p-value<0.05 and absolute
log2FC 0.585. The log2FC was also used to determine whether a gene is upregulated
Functional analysis of the 259 differentially expressed genes revealed that these
were involved in several Gene Ontology (GO) terms: 29 biological processes, 8 cellular
Immune system process was the most significantly enriched biological process
having the smallest p-value (1.54E-09) based on Benjamini method. However, only T
cell differentiation showed a 100% downregulation. T cell is a type of white blood cell
that is an essential component of the immune system and when activated, it can kill a
foreign cell. T cells arise from bone marrow and differentiate in the thymus gland.
T cell receptor complex was the most overrepresented cellular component and
had 100% downregulation. Its child term, alpha-beta T cell receptor complex, also had a
100% downregulation. These two were associated with the aforementioned biological
can be achieved by receptors of the T cell and the APC. With this decreased expression
Cytokine binding, cytokine receptor activity, and receptor activity were the
messenger. Its subtype interleukins are involved in the regulation of T cell and some are
cell differentiation and T cell receptor complex. The remaining genes, those with
hematopoietic cell lineage and T cell receptor signaling pathway, both were associated
with the adaptive immune response. In contrast to innate immune response, adaptive
Hematopoietic stem cell gives rise to two different progenitor cells: myeloid and
lymphoid. Myeloid progenitor cells differentiate to red blood cells, macrophages, and
dendritic cells. On the other hand, lymphoid progenitor cells differentiate to natural killer
cells, B, and T lymphocytes. Only interleukin 1 receptor types I and II were upregulated.
These two genes encode receptor for proteins that participate in inflammatory response.
The only upregulated gene in the T cell receptor signaling pathway was the
mitogen-activated protein kinase 14. The kinase encoded by this gene is activated by
the expression of the remaining genes. The same mechanism could also explain why
most of the gene ontology terms do not exhibit 100 % downregulation or upregulation.
Figure 2 Network of DE genes and the genetic variants. The genetic variant
interleukin-6 had the most number of protein interactions, having 4 nodes connected
to it. Two differentially expressed genes from this study, arginase 1 and CD163
interact with IL-6. Interleukin-6 is a pro-inflammatory cytokine released by the brain
during harmful stimuli. However, uncontrolled or prolonged inflammation can lead to
cell damage. This response is then shifted to an anti-inflammatory action of arginase
1, which also functions in converting arginine into prolines and polyamines in tissue
remodeling. (Cherry,2014) Arginase 1 also had the highest log2FC value in this study.
Furthermore, CD163 is an interleukin-6-regulated receptor for hemoglobin
scavenging and has an anti-inflammatory function. (Moller, 2002) The IL-6 is a
multifunctional cytokine which also exerts anti-inflammatory action on monocytes and
induces the upregulation of CD163. (Buechler, 2000). The CD163 was found to be
upregulated, with log2FC value of 1.015.Another genetic variant TNFRSF13B was
found to interact with a differentially expressed gene, CD27. The TNFRSF13B protein
directs the expression of another protein called TACI on B cell, producer of
antibodies. The highest expression of TACI was found on CD27 + B cell (memory
cell). (Salzer, 2005) The log2FC value of CD27 was found low at -1.025, thus it was
downregulated. This decreased expression of a memory cell marker could result to
re-occurrence of an aneurysm.
11
repair. However, the rest of the genes associated to immune system have decreased
aneurysm cases.
immune system specifically T cell differentiation, T cell receptor signaling pathway, and
These mediators were possibly working for wound repair. However, this repair was not
expressed in this study. However, genes found to interact with these variants play
memory. With the downregulation of gene associated to memory cell, aneurysm could
form again.
Different threshold values could significantly alter the data due to the limited
References
Barrett, J., & Kawasaki, E. S. (2003). Microarrays: The use of oligonucleotides and
cDNA for the analysis of gene expression. Drug Discovery Today, 8(3), 134-141.
doi:10.1016/s1359-6446(02)02578-3
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful
approach to multiple testing. J R Stat Soc Series B.1995;57:289 300.
Cerebral Aneurysms Fact Sheet. (2013). Retrieved August 17, 2016, from
http://www.ninds.nih.gov/disorders/cerebral_aneurysm/detail_cerebral_aneu
rysms.htm
Chalouhi, N., Hoh, B. L., & Hasan, D. (2013). Review of Cerebral Aneurysm Formation,
Growth, and Rupture. Stroke, 44(12), 3613-3622.
doi:10.1161/strokeaha.113.002390
Du P, Kibbe WA, Lin SM. Lumi: a pipeline for processing illumine microarray.
Bioinformatics. 2008;24:15471548.
Huang DW, Sherman BT, Tan Q, Collins JR, Alvord WG, Roayaei J et al. The DAVID
Gene Functional Classification Tool: a novel biological module-centric algorithm
to functionally analyze large gene lists. Genome Biol 2007; 8: R183.
Karp, G. (2013). Cell and Molecular Biology: Concepts and Experiments. Hoboken, NJ:
John Wiley & Sons.
Krischek, B., Kasuya, H., Tajima, A., Akagawa, H., Sasaki, T., Yoneyama, T., . . . Inoue,
I. (2008). Network-based gene expression analysis of intracranial aneurysm
tissue reveals role of antigen presenting cells. Neuroscience, 154(4), 1398-1407.
doi:10.1016/j.neuroscience.2008.
04.049
Kurki, M. I., Hkkinen, S., Frsen, J., Tulamo, R., Fraunberg, M. V., Wong, G., . . . Yl-
Herttuala, S. (2011). Upregulated Signaling Pathways in Ruptured Human
Saccular Intracranial Aneurysm Wall: An Emerging Regulative Role of Toll-Like
Receptor Signaling and Nuclear Factor-B, Hypoxia-Inducible Factor-1A, and
ETS Transcription Factors. Neurosurgery, 68(6), 1667-1676.
doi:10.1227/neu.0b013e318210f001
Nacu, S., Critchley-Thorne, R., Lee, P., & Holmes, S. (2007). Gene expression network
analysis and applications to immunology. Bioinformatics, 23(7), 850-858.
doi:10.1093/bioinformatics/btm019
Nakaoka, H., Tajima, A., Yoneyama, T., Hosomichi, K., Kasuya, H., Mizutani, T., &
Inoue, I. (2014). Gene Expression Profiling Reveals Distinct Molecular
Signatures Associated With the Rupture of Intracranial Aneurysm. Stroke, 45 (8),
2239-2245. doi:10.1161/strokeaha.114.005851
Pera, J., Korostynski, M., Krzyszkowski, T., Czopek, J., Slowik, A., Dziedzic, T., . . .
Szczudlik, A. (2009). Gene Expression Profiles in Human Ruptured and
Unruptured Intracranial Aneurysms: What Is the Role of Inflammation?. Stroke,
41 (2), 224-231. doi:10.1161/strokeaha.109.562009
Pera, J., Korostynski, M., Piechota, M., Golda, S., Krupa, M., Moskala, M., . . . Slowik,
A. (2012). Gene Expression Profiling in Peripheral Blood in Ruptured Intracranial
Aneurysm (S23.006). Neurology, 78. doi:10.1212/w
nl.78.1_meetingabstracts.s23.006
Rinkel GJ, Algra A. Long-term outcomes of patients with aneurysmal subarachnoid
hemorrhage. Lancet Neurol 2011; 10: 349356.
Rinkel GJ, Djibuti M, Algra A, van Gijn J. Prevalence and risk of rupture of intracranial
aneurysms: a systematic review. Stroke. 1998;29:251256.
14
Shi, C., Awad, I. A., Jafari, N., Lin, S., Du, P., Hage, Z. A., . . . Bendok, B. R. (2009).
Genomics of Human Intracranial Aneurysm Wall. Stroke, 40(4), 1252-1261.
doi:10.1161/strokeaha.108.532036
Tarca, A. L., Romero, R., & Draghici, S. (2006). Analysis of microarray experiments of
gene expression profiling. American Journal of Obstetrics and Gynecology, 195
(2), 373-388. doi:10.1016/j.ajog.2006.07.001
Tromp, G., Weinsheimer, S., Ronkainen, A., & Kuivaniemi, H. (2014). Molecular basis
and genetic predisposition to intracranial aneurysm. Annals of Medicine, 46 (8),
597-606. doi:10.3109/07853890.2014.949299
Wardlaw JM, White PM. The detection and management of unruptured intracranial
aneurysms. Brain 2000;123(pt 2):205-21.
Wiebers DO, Whisnant JP, Huston J III, et al. Unruptured intracranial aneurysms:
natural history, clinical outcome, and risks of surgical and endovascular
treatment. Lancet 2003;362:103110.888.